New radiation dose may tame eye cancer with fewer side effects
NCT ID NCT07210749
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a lower dose of radiation (12 Gy in 6 sessions) for people with low-grade B-cell orbital lymphoma, a slow-growing eye cancer. The goal is to see if this dose can control the tumor as well as the standard higher dose (24-25 Gy) while causing fewer long-term side effects. About 36 adults with this condition will take part. If successful, this approach could offer a gentler treatment option.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ORBITAL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
BC Cancer Vancouver
Vancouver, British Columbia, V5Z4E6, Canada